Redirecting to https://www.tradingview.com/news/reuters.com,2026:newsml_TUA9TDMVP:0-lantern-pharma-announces-successful-outcome-of-fda-type-c-meeting-request-for-harmonic-phase-2-trial-of-lp-300-in-never-smokers-with-nsclc/